首页 > 最新文献

International Journal of Evidence-Based Healthcare最新文献

英文 中文
Effectiveness of interpretive front-of-pack nutritional labelling schemes on the promotion of healthier food choices: a systematic review. 解释性包装正面营养标签计划对促进健康食物选择的有效性:系统回顾。
Q3 Medicine Pub Date : 2020-03-01 DOI: 10.1097/XEB.0000000000000214
Rodrigo Feteira-Santos, João Fernandes, Ana Virgolino, Violeta Alarcão, Catarina Sena, Carlota P Vieira, Maria João Gregório, Paulo Nogueira, Andreia Costa, Pedro Graça, Osvaldo Santos

Aims: Interpretive front-of-package nutrition labelling can contribute to healthier food habits. This systematic review aimed to examine the effectiveness of interpretive front-of-package nutrition labelling schemes on consumers' food choices, namely at the moment of food purchase, and to analyse if this potential front-of-package nutrition labelling's effect varies according to different socioeconomic groups.

Methods: Electronic databases (Cochrane Library, PubMed, Scopus, and Web of Science) search was performed to identify peer-reviewed articles describing longitudinal studies evaluating the effect of front-of-package nutrition labelling schemes on consumers' food choices, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Equity 2012 Extension guidelines. No publication-period or language restrictions were applied. PROGRESS-Plus framework was used to report if and how socioeconomic factors were considered in analyses of front-of-package nutrition labelling-related interventions' effect.

Results: Nine studies were selected for narrative synthesis (seven randomized controlled trials and two cross-over trials). When compared with no-interpretive-label conditions, front-of-package nutrition labelling showed a positive impact for nutritional content understanding, healthiness perception of products, selection of products with better nutritional quality, and purchase intention. However, there is no robust evidence of superiority of a specific front-of-package nutrition labelling scheme's effect, neither on consumers' understanding of nutritional content nor on food choices. An evaluation of the studies following the PROGRESS-Plus framework revealed that socioecononomic status and education were the most frequently used dimensions, when assessing the effect of interpretative front-of-pack nutrition labels. More evidence is necessary to determine the role of front-of-pack nutrition labels in decreasing inequalities between different population subgroups, namely among the most vulnerable subgroups, on the promotion of healthy food choices.

Conclusion: Well controlled longitudinal studies, following a real-world evidence approach, are needed to clarify front-of-package nutrition labelling's impact on consumers' food choices, namely at purchase points, taking into account the most vulnerable population subgroups, such as those with lower literacy and/or financial resources.

目的:解释性包装正面营养标签可以促进健康的饮食习惯。本系统综述旨在检验包装正面营养标签解释方案对消费者食品选择的有效性,即在购买食品的那一刻,并分析这种包装正面营养标签的潜在影响是否因不同的社会经济群体而异。方法:电子数据库(Cochrane Library, PubMed, Scopus和Web of Science)进行检索,根据系统评价和荟萃分析(PRISMA)-Equity 2012扩展指南的首选报告项目,确定描述纵向研究评估包装前营养标签方案对消费者食品选择影响的同行评议文章。没有对出版期限或语言加以限制。PROGRESS-Plus框架用于报告在分析包装前营养标签相关干预措施的影响时是否以及如何考虑社会经济因素。结果:选择9项研究进行叙事综合(7项随机对照试验和2项交叉试验)。与无解释标签的情况相比,包装正面营养标签对营养成分的理解、产品的健康感知、选择营养质量更好的产品和购买意愿有积极的影响。然而,无论是对消费者对营养成分的理解还是对食物的选择,都没有强有力的证据表明特定的包装正面营养标签方案的优势。对PROGRESS-Plus框架下的研究进行的评估显示,在评估包装正面解释性营养标签的影响时,社会经济地位和教育是最常用的维度。需要更多的证据来确定包装正面营养标签在减少不同人口亚群体之间,即最脆弱的亚群体之间在促进健康食品选择方面的不平等方面的作用。结论:需要进行对照良好的纵向研究,遵循真实世界的证据方法,以澄清包装正面营养标签对消费者食品选择的影响,即在购买点,考虑到最脆弱的人群亚群体,如文化水平较低和/或经济资源较低的人群。
{"title":"Effectiveness of interpretive front-of-pack nutritional labelling schemes on the promotion of healthier food choices: a systematic review.","authors":"Rodrigo Feteira-Santos,&nbsp;João Fernandes,&nbsp;Ana Virgolino,&nbsp;Violeta Alarcão,&nbsp;Catarina Sena,&nbsp;Carlota P Vieira,&nbsp;Maria João Gregório,&nbsp;Paulo Nogueira,&nbsp;Andreia Costa,&nbsp;Pedro Graça,&nbsp;Osvaldo Santos","doi":"10.1097/XEB.0000000000000214","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000214","url":null,"abstract":"<p><strong>Aims: </strong>Interpretive front-of-package nutrition labelling can contribute to healthier food habits. This systematic review aimed to examine the effectiveness of interpretive front-of-package nutrition labelling schemes on consumers' food choices, namely at the moment of food purchase, and to analyse if this potential front-of-package nutrition labelling's effect varies according to different socioeconomic groups.</p><p><strong>Methods: </strong>Electronic databases (Cochrane Library, PubMed, Scopus, and Web of Science) search was performed to identify peer-reviewed articles describing longitudinal studies evaluating the effect of front-of-package nutrition labelling schemes on consumers' food choices, according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-Equity 2012 Extension guidelines. No publication-period or language restrictions were applied. PROGRESS-Plus framework was used to report if and how socioeconomic factors were considered in analyses of front-of-package nutrition labelling-related interventions' effect.</p><p><strong>Results: </strong>Nine studies were selected for narrative synthesis (seven randomized controlled trials and two cross-over trials). When compared with no-interpretive-label conditions, front-of-package nutrition labelling showed a positive impact for nutritional content understanding, healthiness perception of products, selection of products with better nutritional quality, and purchase intention. However, there is no robust evidence of superiority of a specific front-of-package nutrition labelling scheme's effect, neither on consumers' understanding of nutritional content nor on food choices. An evaluation of the studies following the PROGRESS-Plus framework revealed that socioecononomic status and education were the most frequently used dimensions, when assessing the effect of interpretative front-of-pack nutrition labels. More evidence is necessary to determine the role of front-of-pack nutrition labels in decreasing inequalities between different population subgroups, namely among the most vulnerable subgroups, on the promotion of healthy food choices.</p><p><strong>Conclusion: </strong>Well controlled longitudinal studies, following a real-world evidence approach, are needed to clarify front-of-package nutrition labelling's impact on consumers' food choices, namely at purchase points, taking into account the most vulnerable population subgroups, such as those with lower literacy and/or financial resources.</p>","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/XEB.0000000000000214","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37507604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
The fragility of randomized trial outcomes underlying management of dyspepsia and Helicobacter pylori infections. 消化不良和幽门螺杆菌感染管理的随机试验结果的脆弱性。
Q3 Medicine Pub Date : 2020-03-01 DOI: 10.1097/XEB.0000000000000203
Chase Meyer, Aaron Bowers, Daniel Tritz, Kaleb Fuller, C. Wayant, Courtney Cook, Trevor Torgerson, M. Som, M. Vassar
AIMThe fragility index is calculated by changing one outcome event to a nonevent within a trial until the associated P value exceeds 0.05. In this study, we assessed the robustness, risk of bias (RoB), and power of randomized controlled trials that underlie recommendations set forth by the American College of Gastroenterology (ACG) on managing dyspepsia and Helicobacter pylori infections.METHODSAll citations referenced in the guidelines were screened for inclusion criteria. The fragility indexes for eligible trials were then calculated. The likelihood and sources of bias in the included trials were evaluated by the Cochrane 'RoB' Tool 2.0.RESULTSThe median fragility index for the 52 trials was three events. Five studies (9.6%) resulted in a fragility index of 0 when statistical analysis was applied. For the 52 trials, 12 (23.1%) were at a low RoB, 15 (28.8%) had some concerns, and 25 (48.1%) were at a high RoB. High RoB was most commonly due to bias of selection in the reported result (15.5%).CONCLUSIONA median of three events was needed to nullify statistical significance in 52 trials that underpin guideline recommendations on the management of dyspepsia and H. pylori infections. In addition, concerns for RoB were found for these trials.
脆弱性指数通过将试验中的一个结果事件更改为非事件来计算,直到相关P值超过0.05。在这项研究中,我们评估了随机对照试验的稳健性、偏倚风险(RoB)和有效性,这些随机对照试验是美国胃肠病学学会(ACG)提出的治疗消化不良和幽门螺杆菌感染建议的基础。方法对指南中引用的所有文献进行筛选,确定纳入标准。然后计算符合条件的试验的脆弱性指数。采用Cochrane“RoB”工具2.0评估纳入试验的偏倚可能性和偏倚来源。结果52项试验的脆弱性指数中位数为3个事件。经统计分析,脆弱性指数为0的研究有5项(9.6%)。在52个试验中,12个(23.1%)处于低RoB, 15个(28.8%)有一些担忧,25个(48.1%)处于高RoB。高RoB最常见的原因是报告结果中的选择偏差(15.5%)。结论:在消化不良和幽门螺杆菌感染管理指南推荐的52项试验中,需要3个事件的中位数来消除统计学意义。此外,在这些试验中发现了对罗伯的担忧。
{"title":"The fragility of randomized trial outcomes underlying management of dyspepsia and Helicobacter pylori infections.","authors":"Chase Meyer, Aaron Bowers, Daniel Tritz, Kaleb Fuller, C. Wayant, Courtney Cook, Trevor Torgerson, M. Som, M. Vassar","doi":"10.1097/XEB.0000000000000203","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000203","url":null,"abstract":"AIM\u0000The fragility index is calculated by changing one outcome event to a nonevent within a trial until the associated P value exceeds 0.05. In this study, we assessed the robustness, risk of bias (RoB), and power of randomized controlled trials that underlie recommendations set forth by the American College of Gastroenterology (ACG) on managing dyspepsia and Helicobacter pylori infections.\u0000\u0000\u0000METHODS\u0000All citations referenced in the guidelines were screened for inclusion criteria. The fragility indexes for eligible trials were then calculated. The likelihood and sources of bias in the included trials were evaluated by the Cochrane 'RoB' Tool 2.0.\u0000\u0000\u0000RESULTS\u0000The median fragility index for the 52 trials was three events. Five studies (9.6%) resulted in a fragility index of 0 when statistical analysis was applied. For the 52 trials, 12 (23.1%) were at a low RoB, 15 (28.8%) had some concerns, and 25 (48.1%) were at a high RoB. High RoB was most commonly due to bias of selection in the reported result (15.5%).\u0000\u0000\u0000CONCLUSION\u0000A median of three events was needed to nullify statistical significance in 52 trials that underpin guideline recommendations on the management of dyspepsia and H. pylori infections. In addition, concerns for RoB were found for these trials.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90542627","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The value of uncertainty: the Zika and Microcefalia link 不确定性的价值:寨卡病毒和小儿科的联系
Q3 Medicine Pub Date : 2019-12-20 DOI: 10.17267/2675-021xevidence.v1i2.2541
Denise Silva Matias, Luis Cláudio Lemos Correia, Daniel Oliveira Medina da Silva, Larrie Rabelo Laporte, Camila Verônica Souza Freire, Gabriel De Araújo Grisi, Thiago Masashi Taniguchi, Mariana Correia Moreira Cruz
Scientific paradigm violations are common in the medical literature. This article aims to describe the principles that should guide scientific thinking, such as the philosophy of skepticism, the consideration of multiple hypothesis, epidemiological criteria to demonstrate association, concern about random errors and the need to quantify the strength of association. We use the hypothesis of causality between Zika and microcephaly to illustrate these principles and cognitive mechanisms that predispose to its violation. This is an example of dissociation between certainty and level of evidence, since the association between these two entities was confirmed at a time when there was no evidence of quality that supported this association.
违反科学范式在医学文献中很常见。本文旨在描述应指导科学思维的原则,如怀疑主义哲学、对多种假设的考虑、证明关联的流行病学标准、对随机误差的关注以及量化关联强度的必要性。我们使用寨卡病毒和小头症之间的因果关系假设来说明这些原则和容易违反的认知机制。这是确定性和证据水平分离的一个例子,因为这两个实体之间的联系是在没有质量证据支持这种联系的情况下得到证实的。
{"title":"The value of uncertainty: the Zika and Microcefalia link","authors":"Denise Silva Matias, Luis Cláudio Lemos Correia, Daniel Oliveira Medina da Silva, Larrie Rabelo Laporte, Camila Verônica Souza Freire, Gabriel De Araújo Grisi, Thiago Masashi Taniguchi, Mariana Correia Moreira Cruz","doi":"10.17267/2675-021xevidence.v1i2.2541","DOIUrl":"https://doi.org/10.17267/2675-021xevidence.v1i2.2541","url":null,"abstract":"Scientific paradigm violations are common in the medical literature. This article aims to describe the principles that should guide scientific thinking, such as the philosophy of skepticism, the consideration of multiple hypothesis, epidemiological criteria to demonstrate association, concern about random errors and the need to quantify the strength of association. We use the hypothesis of causality between Zika and microcephaly to illustrate these principles and cognitive mechanisms that predispose to its violation. This is an example of dissociation between certainty and level of evidence, since the association between these two entities was confirmed at a time when there was no evidence of quality that supported this association.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74658315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selecting the best meta-analytic estimator for evidence-based practice: a simulation study. 为循证实践选择最佳元分析估计量:一项模拟研究。
Q3 Medicine Pub Date : 2019-11-20 DOI: 10.1097/XEB.0000000000000207
S. Doi, L. Furuya-Kanamori
Studies included in meta-analysis can produce results that depart from the true population parameter of interest due to systematic and/or random errors. Synthesis of these results in meta-analysis aims to generate an estimate closer to the true population parameter by minimizing these errors across studies. The inverse variance heterogeneity (IVhet), quality effects and random effects models of meta-analysis all attempt to do this, but there remains controversy around the estimator that best achieves this goal of reducing error. In an attempt to answer this question, a simulation study was conducted to compare estimator performance. Five thousand iterations at 10 different levels of heterogeneity were run, with each iteration generating one meta-analysis. The results demonstrate that the IVhet and quality effects estimators, though biased, have the lowest mean squared error. These estimators also achieved a coverage probability at or above the nominal level (95%), whereas the coverage probability under the random effects estimator significantly declined (<80%) as heterogeneity increased despite a similar confidence interval width. Based on our findings, we would recommend the use of the IVhet and quality effects models and a discontinuation of traditional random effects models currently in use for meta-analysis.
由于系统和/或随机误差,纳入meta分析的研究可能产生偏离真实总体参数的结果。在荟萃分析中综合这些结果的目的是通过最小化研究中的这些误差来产生更接近真实总体参数的估计。meta分析的逆方差异质性(IVhet)、质量效应和随机效应模型都试图做到这一点,但围绕最能实现减少误差目标的估计量仍存在争议。为了回答这个问题,我们进行了仿真研究来比较估计器的性能。在10个不同的异质性水平上运行5000次迭代,每次迭代生成一个元分析。结果表明,ivht和质量效应估计器虽然有偏,但均方误差最小。这些估计器也达到了等于或高于名义水平(95%)的覆盖概率,而随机效应估计器下的覆盖概率随着异质性的增加而显著下降(<80%),尽管置信区间宽度相似。根据我们的研究结果,我们建议使用IVhet和质量效应模型,并停止目前用于荟萃分析的传统随机效应模型。
{"title":"Selecting the best meta-analytic estimator for evidence-based practice: a simulation study.","authors":"S. Doi, L. Furuya-Kanamori","doi":"10.1097/XEB.0000000000000207","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000207","url":null,"abstract":"Studies included in meta-analysis can produce results that depart from the true population parameter of interest due to systematic and/or random errors. Synthesis of these results in meta-analysis aims to generate an estimate closer to the true population parameter by minimizing these errors across studies. The inverse variance heterogeneity (IVhet), quality effects and random effects models of meta-analysis all attempt to do this, but there remains controversy around the estimator that best achieves this goal of reducing error. In an attempt to answer this question, a simulation study was conducted to compare estimator performance. Five thousand iterations at 10 different levels of heterogeneity were run, with each iteration generating one meta-analysis. The results demonstrate that the IVhet and quality effects estimators, though biased, have the lowest mean squared error. These estimators also achieved a coverage probability at or above the nominal level (95%), whereas the coverage probability under the random effects estimator significantly declined (<80%) as heterogeneity increased despite a similar confidence interval width. Based on our findings, we would recommend the use of the IVhet and quality effects models and a discontinuation of traditional random effects models currently in use for meta-analysis.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86884358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Patients' and physicians' perspectives and experiences on the quality of medical consultations: a qualitative evidence. 患者和医生对医疗咨询质量的看法和经验:定性证据。
Q3 Medicine Pub Date : 2019-11-09 DOI: 10.1097/XEB.0000000000000210
M. Bahadori, M. Yaghoubi, Elaheh Haghgoshyie, Matina Ghasemi, E. Hasanpoor
AIMMedical consultation is not only one of the most important steps in disease diagnosis and patient treatment, but also every patient's right. The purpose of this review was to explore patients' and physicians' perspectives and experiences of the quality of medical consultations.METHODSA qualitative interview study was carried out in outpatient clinics. A combination of face-to-face and telephone interviews was used due to the geographical spread of the respondents. Interviews were recorded and transcribed verbatim. Thematic descriptive analysis was used to interpret the data. Eligible physicians (n = 21) and patients (n = 27) were invited to take part in a semistructured interview to explore the views, perceptions, and experiences of patients on various factors affecting the quality of medical consultations.RESULTSThe consultation quality was categorized into three topics: structure quality, process quality, and outcome quality. Data synthesis identified the following major themes for structure quality of consultations: administrative-organizational quality (with eight subthemes), physical environment quality (with six subthemes), and educational quality (with three subthemes). In addition, process quality was categorized into two major themes: examination quality (with nine subthemes) and interpersonal quality (with 13 subthemes). Outcome quality consisted of three major themes: patient satisfaction (with four subthemes), clinical outcomes (with two subthemes), and organizational outcomes (with three subthemes).CONCLUSIONMedical consultation plays a central role in the quality and effectiveness of the received health care. Using the indicators of consultation quality improvement can develop physicians' clinical competence and skills. Furthermore, decision-makers can use them to monitor and evaluate physicians' performance.
医疗会诊不仅是疾病诊断和患者治疗的重要步骤之一,也是每一位患者的权利。本综述的目的是探讨患者和医生对医疗咨询质量的看法和经验。方法在门诊进行定性访谈研究。由于受访者的地理分布,使用了面对面和电话访谈的结合。采访被逐字记录和抄写。采用专题描述性分析对数据进行解释。我们邀请符合条件的医生(n = 21)和患者(n = 27)参加半结构化访谈,以探讨患者对影响医疗咨询质量的各种因素的看法、看法和经验。结果会诊质量分为结构质量、过程质量和结果质量三个主题。数据综合确定了协商结构质量的下列主要主题:行政组织质量(有八个分主题)、自然环境质量(有六个分主题)和教育质量(有三个分主题)。此外,过程质量被分为两大主题:考试质量(有9个子主题)和人际质量(有13个子主题)。结果质量包括三个主要主题:患者满意度(四个次要主题)、临床结果(两个次要主题)和组织结果(三个次要主题)。结论医学咨询是影响医疗服务质量和效果的重要因素。利用会诊质量改善指标可以提高医师的临床能力和技能。此外,决策者可以使用它们来监测和评估医生的表现。
{"title":"Patients' and physicians' perspectives and experiences on the quality of medical consultations: a qualitative evidence.","authors":"M. Bahadori, M. Yaghoubi, Elaheh Haghgoshyie, Matina Ghasemi, E. Hasanpoor","doi":"10.1097/XEB.0000000000000210","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000210","url":null,"abstract":"AIM\u0000Medical consultation is not only one of the most important steps in disease diagnosis and patient treatment, but also every patient's right. The purpose of this review was to explore patients' and physicians' perspectives and experiences of the quality of medical consultations.\u0000\u0000\u0000METHODS\u0000A qualitative interview study was carried out in outpatient clinics. A combination of face-to-face and telephone interviews was used due to the geographical spread of the respondents. Interviews were recorded and transcribed verbatim. Thematic descriptive analysis was used to interpret the data. Eligible physicians (n = 21) and patients (n = 27) were invited to take part in a semistructured interview to explore the views, perceptions, and experiences of patients on various factors affecting the quality of medical consultations.\u0000\u0000\u0000RESULTS\u0000The consultation quality was categorized into three topics: structure quality, process quality, and outcome quality. Data synthesis identified the following major themes for structure quality of consultations: administrative-organizational quality (with eight subthemes), physical environment quality (with six subthemes), and educational quality (with three subthemes). In addition, process quality was categorized into two major themes: examination quality (with nine subthemes) and interpersonal quality (with 13 subthemes). Outcome quality consisted of three major themes: patient satisfaction (with four subthemes), clinical outcomes (with two subthemes), and organizational outcomes (with three subthemes).\u0000\u0000\u0000CONCLUSION\u0000Medical consultation plays a central role in the quality and effectiveness of the received health care. Using the indicators of consultation quality improvement can develop physicians' clinical competence and skills. Furthermore, decision-makers can use them to monitor and evaluate physicians' performance.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88931427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Focus is the new intelligence quotient for evidence-based practice. 专注是循证实践的新智商。
Q3 Medicine Pub Date : 2019-11-09 DOI: 10.1097/XEB.0000000000000211
Z. Jordan
The focus of most individuals and organizations working in the field of evidence-based healthcare (EBHC) is to operationalize evidence. Few would argue that the primary driver and ultimate objective of EBHC is to see it utilized to inform policy and practice that results in improved outcomes for patients. However, it is hard not to think of the infinity pool as a metaphor for the potentially limitless endeavour of methodological reflection, refinement and reconceptualization that many of us as evidence-based researchers seek to achieve. Diving into ‘methodological infinity pools’ (or down rabbit holes – you can choose whichever symbolism or imagery works best for you) can result in fresh, unexpected salience. There is no doubt that some benefit can come from considering tangential ways of thinking about some of the problems we seek to solve. Nevertheless, these tangents are not always necessarily productive or pragmatic and need to be tempered accordingly. The value proposition of systematic reviews in this context has been their ability to provide rigorously reviewed and synthesized trustworthy evidence. It is therefore critical that we deliver on that promise and invest in ensuring the highest quality result for key stakeholders. To that end, methodological advances in the science and timely delivery and update of evidence syntheses continue at a rapid rate. A considerable number of new methodological approaches are now appearing for different types of evidence, and there are also an increasing number of tools available to assist in improving reporting and methodological quality in the conduct of systematic reviews (QUOROM, PRISMA, AMSTAR, COSMIN, MOOSE, OQAQ, ROBIS). However, despite the existence of such tools common errors persist, including use of incomplete guidance, incorrect use of reporting tools and checklists or use of tolls in isolation without reference to methodological guidance for the conduct of reviews. Significant criticism has also been levelled at the science that currently underpins the conduct of systematic reviews and, in particular, meta-analyses. Prominent, experienced synthesis science scholars like John Ionnidis and Jos Kleijnen (among others) have been frequently cited for their observations regarding issues related to
在循证医疗(EBHC)领域工作的大多数个人和组织的重点是操作证据。很少有人会认为EBHC的主要驱动因素和最终目标是看到它被用于为政策和实践提供信息,从而改善患者的预后。然而,我们很难不把无限大的水池看作是对方法论反思、改进和重新概念化的潜在无限努力的隐喻,这是我们许多以证据为基础的研究人员寻求实现的目标。潜入“方法论的无限池”(或者进入兔子洞——你可以选择最适合你的象征或意象)可以带来新鲜的、意想不到的突出。毫无疑问,从切线的角度来考虑我们想要解决的一些问题会带来一些好处。然而,这些切线并不一定总是富有成效或实用的,需要相应地加以调整。在这种情况下,系统评论的价值主张是它们提供严格审查和合成可信证据的能力。因此,至关重要的是,我们要兑现这一承诺,并投资于确保为关键利益相关者提供最高质量的结果。为此目的,科学方面的方法学进步以及及时提供和更新综合证据继续快速进行。对于不同类型的证据,现在出现了相当多的新的方法方法,并且在进行系统评价时,也有越来越多的工具可用于帮助改善报告和方法质量(QUOROM, PRISMA, AMSTAR, COSMIN, MOOSE, OQAQ, ROBIS)。然而,尽管存在这些工具,常见的错误仍然存在,包括使用不完整的指导,不正确地使用报告工具和检查清单,或在不参考进行审查的方法指导的情况下孤立地使用收费。对目前支撑系统评价,特别是荟萃分析的科学也提出了重大批评。杰出的、经验丰富的合成科学学者,如John Ionnidis和Jos Kleijnen(以及其他人),经常被引用,因为他们对相关问题的观察
{"title":"Focus is the new intelligence quotient for evidence-based practice.","authors":"Z. Jordan","doi":"10.1097/XEB.0000000000000211","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000211","url":null,"abstract":"The focus of most individuals and organizations working in the field of evidence-based healthcare (EBHC) is to operationalize evidence. Few would argue that the primary driver and ultimate objective of EBHC is to see it utilized to inform policy and practice that results in improved outcomes for patients. However, it is hard not to think of the infinity pool as a metaphor for the potentially limitless endeavour of methodological reflection, refinement and reconceptualization that many of us as evidence-based researchers seek to achieve. Diving into ‘methodological infinity pools’ (or down rabbit holes – you can choose whichever symbolism or imagery works best for you) can result in fresh, unexpected salience. There is no doubt that some benefit can come from considering tangential ways of thinking about some of the problems we seek to solve. Nevertheless, these tangents are not always necessarily productive or pragmatic and need to be tempered accordingly. The value proposition of systematic reviews in this context has been their ability to provide rigorously reviewed and synthesized trustworthy evidence. It is therefore critical that we deliver on that promise and invest in ensuring the highest quality result for key stakeholders. To that end, methodological advances in the science and timely delivery and update of evidence syntheses continue at a rapid rate. A considerable number of new methodological approaches are now appearing for different types of evidence, and there are also an increasing number of tools available to assist in improving reporting and methodological quality in the conduct of systematic reviews (QUOROM, PRISMA, AMSTAR, COSMIN, MOOSE, OQAQ, ROBIS). However, despite the existence of such tools common errors persist, including use of incomplete guidance, incorrect use of reporting tools and checklists or use of tolls in isolation without reference to methodological guidance for the conduct of reviews. Significant criticism has also been levelled at the science that currently underpins the conduct of systematic reviews and, in particular, meta-analyses. Prominent, experienced synthesis science scholars like John Ionnidis and Jos Kleijnen (among others) have been frequently cited for their observations regarding issues related to","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84457889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Splenectomy associated with increased risk of herpes zoster in a population-based cohort study. 在一项基于人群的队列研究中,脾切除术与带状疱疹风险增加相关。
Q3 Medicine Pub Date : 2019-11-04 DOI: 10.1097/XEB.0000000000000206
S. Lai, Cheng-Li Lin, K. Liao
BACKGROUND/OBJECTIVENo systematic research focuses on the association between splenectomy and herpes zoster. This study aimed to investigate the association between splenectomy and herpes zoster in Taiwan.METHODSA population-based cohort study was conducted using the database of Taiwan National Health Insurance Program. There were 640 individuals aged 20-84 years who were newly diagnosed with splenectomy in 2000-2012 as the splenectomy group and 2546 sex-matched and age-matched individuals without splenectomy as the nonsplenectomy group. The incidence of herpes zoster at the end of 2013 was estimated. The multivariable Cox proportional hazards regression model was used to estimate the hazard ratio and 95% confidence interval (CI) for herpes zoster associated with splenectomy.RESULTSThe overall incidence of herpes zoster was 1.41-fold higher in the splenectomy group than in the nonsplenectomy group (11.3 vs. 8.05 per 1000 person-years, 95% CI 1.11-1.78). After multivariable adjustments, the adjusted hazard ratio of herpes zoster was 1.57 for individuals with splenectomy (95% CI 1.08-2.29), compared with individuals without splenectomy.CONCLUSIONIndividuals with splenectomy are associated with 1.57-fold increased risk for developing herpes zoster in Taiwan. Vaccination against herpes zoster may be considered among these high-risk individuals.
背景/目的目前还没有系统的研究关注脾切除术与带状疱疹的关系。摘要本研究旨在探讨台湾地区脾切除术与带状疱疹的关系。方法采用台湾全民健保数据库进行人群队列研究。2000-2012年新诊断的20-84岁脾切除术患者640例作为脾切除术组,性别匹配和年龄匹配的未脾切除术患者2546例作为非脾切除术组。估计2013年底带状疱疹的发病率。采用多变量Cox比例风险回归模型估计带状疱疹伴脾切除术的风险比和95%置信区间(CI)。结果脾切除术组带状疱疹的总发病率是未脾切除术组的1.41倍(11.3 vs. 8.05 / 1000人年,95% CI 1.11-1.78)。经多变量校正后,与未行脾切除术的患者相比,行脾切除术的患者患带状疱疹的校正危险比为1.57 (95% CI 1.08-2.29)。结论台湾地区行脾切除术者发生带状疱疹的风险增加1.57倍。这些高危人群可考虑接种带状疱疹疫苗。
{"title":"Splenectomy associated with increased risk of herpes zoster in a population-based cohort study.","authors":"S. Lai, Cheng-Li Lin, K. Liao","doi":"10.1097/XEB.0000000000000206","DOIUrl":"https://doi.org/10.1097/XEB.0000000000000206","url":null,"abstract":"BACKGROUND/OBJECTIVE\u0000No systematic research focuses on the association between splenectomy and herpes zoster. This study aimed to investigate the association between splenectomy and herpes zoster in Taiwan.\u0000\u0000\u0000METHODS\u0000A population-based cohort study was conducted using the database of Taiwan National Health Insurance Program. There were 640 individuals aged 20-84 years who were newly diagnosed with splenectomy in 2000-2012 as the splenectomy group and 2546 sex-matched and age-matched individuals without splenectomy as the nonsplenectomy group. The incidence of herpes zoster at the end of 2013 was estimated. The multivariable Cox proportional hazards regression model was used to estimate the hazard ratio and 95% confidence interval (CI) for herpes zoster associated with splenectomy.\u0000\u0000\u0000RESULTS\u0000The overall incidence of herpes zoster was 1.41-fold higher in the splenectomy group than in the nonsplenectomy group (11.3 vs. 8.05 per 1000 person-years, 95% CI 1.11-1.78). After multivariable adjustments, the adjusted hazard ratio of herpes zoster was 1.57 for individuals with splenectomy (95% CI 1.08-2.29), compared with individuals without splenectomy.\u0000\u0000\u0000CONCLUSION\u0000Individuals with splenectomy are associated with 1.57-fold increased risk for developing herpes zoster in Taiwan. Vaccination against herpes zoster may be considered among these high-risk individuals.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83883078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
A brief history of evidence-based medicine 循证医学简史
Q3 Medicine Pub Date : 2019-10-21 DOI: 10.17267/2675-021xevidence.v1i2.2485
T. Lapa, Marcelo Nunes Dourado Rocha, N. A. Almeida Filho, André Luis Mattedi Dias
{"title":"A brief history of evidence-based medicine","authors":"T. Lapa, Marcelo Nunes Dourado Rocha, N. A. Almeida Filho, André Luis Mattedi Dias","doi":"10.17267/2675-021xevidence.v1i2.2485","DOIUrl":"https://doi.org/10.17267/2675-021xevidence.v1i2.2485","url":null,"abstract":"<jats:p />","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72755960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women 预防青春期少女和妇女宫颈癌前期的人乳头瘤病毒疫苗
Q3 Medicine Pub Date : 2019-10-21 DOI: 10.17267/2675-021xevidence.v1i2.2510
J. Li, Jessica Stetz
The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with HPV16/18. The data also demonstrates an absence of serious adverse events. Therefore, we have assigned a color recommendation of Green (Benefit > Harm) to this vaccine.
Cochrane荟萃分析提供的证据显示,HPV疫苗接种对预防宫颈癌前期有显著益处。预防一名宫颈癌前病变(15至25岁感染或未感染HPV的妇女)的NNT为60。对于与HPV16/18相关的病变,效果更高。数据还表明没有发生严重的不良事件。因此,我们为该疫苗指定了绿色(益处>危害)的推荐颜色。
{"title":"HPV vaccines for prevention of cervical pre-cancer in adolescent girls and women","authors":"J. Li, Jessica Stetz","doi":"10.17267/2675-021xevidence.v1i2.2510","DOIUrl":"https://doi.org/10.17267/2675-021xevidence.v1i2.2510","url":null,"abstract":"The evidence presented in this Cochrane meta-analysis shows the HPV vaccination confers significant benefit in preventing cervical pre-cancer. NNT of 60 for preventing one cervical pre-cancer (women 15 to 25 years old with or without HPV infection). The effect is higher for lesions associated with HPV16/18. The data also demonstrates an absence of serious adverse events. Therefore, we have assigned a color recommendation of Green (Benefit > Harm) to this vaccine.","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75655766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Characteristics of systematic reviews published in dentistry by Brazilian corresponding authors 巴西通讯作者在牙科学上发表的系统综述的特点
Q3 Medicine Pub Date : 2019-10-17 DOI: 10.17267/2675-021xevidence.v1i2.2506
R. Sarkis-Onofre, T. Pereira-Cenci, Rafaela Bassani, M. Page, A. Tricco, D. Moher, M. Cenci, G. K. Pereira
OBJECTIVE: This study aimed to analyze the reporting and conduct characteristics of systematic reviews (SRs) published in dentistry by Brazilian corresponding authors and compare reporting characteristics of Brazilian SRs with the rest of the world. METHODS: A search in PubMed was performed to identify SRs published in dentistry in 2017 assessing different aspects of oral heath irrespective of the design of included studies. From this dataset, a subgroup analysis was performed considering only SRs published by Brazilian corresponding authors. Study screening was performed by two researchers independently, while for data extraction, one of three reviewers extracted details related to reporting and conduct of SRs. The completeness of reporting of 24 characteristics, included in the PRISMA Statement of the SRs classified as treatment/therapeutic, was evaluated comparing Brazilian SR to SRs from all other countries. RESULTS: We included 117 SRs with Brazilian corresponding authors. The majority focused on dental treatments (39.3%), with oral surgery (n=19, 16.2%) as the most commonly published. Included SRs presented varying reporting/conduct characteristics. Items such as use of reporting guidelines and screening method used were well reported. However, most SRs did not assess the risk of publication bias and did not use the GRADE assessment. Four (of 24) reporting characteristics of Brazilian SRs compared to SRs from the rest of world were reported statistically significantly more frequently: mention of a SR protocol, trial registry searched, screening method reported, and assessment of risk of bias/quality of studies. CONCLUSION: Reporting and conduct characteristics of Brazilian SRs are highly variable. 
目的:本研究旨在分析巴西通讯作者在牙科领域发表的系统评价(SRs)的报道和实施特点,并将巴西SRs的报道特点与世界其他地区进行比较。方法:在PubMed中进行检索,以确定2017年发表在牙科领域的SRs,评估口腔健康的不同方面,无论纳入研究的设计如何。从该数据集中,仅考虑巴西通讯作者发表的SRs进行亚组分析。研究筛选由两名研究人员独立进行,而对于数据提取,三名审稿人中的一名提取与SRs报告和行为相关的细节。将巴西SR与所有其他国家的SR进行比较,评估了PRISMA声明中分类为治疗/治疗性SR的24个特征报告的完整性。结果:我们纳入了117例巴西通讯作者的SRs。大多数集中在牙科治疗(39.3%),其中最常见的是口腔外科(n=19, 16.2%)。包括的特别报告提出了不同的报告/行为特征。报告了报告准则的使用情况和使用的筛选方法等项目。然而,大多数SRs没有评估发表偏倚风险,也没有使用GRADE评估。与世界其他地区的SRs相比,巴西SRs的24个报告特征中有4个(共24个)的报告频率在统计学上显著更高:提到SR方案、试验注册库检索、报告的筛选方法以及评估偏倚风险/研究质量。结论:巴西SRs的报告和行为特征变化很大。
{"title":"Characteristics of systematic reviews published in dentistry by Brazilian corresponding authors","authors":"R. Sarkis-Onofre, T. Pereira-Cenci, Rafaela Bassani, M. Page, A. Tricco, D. Moher, M. Cenci, G. K. Pereira","doi":"10.17267/2675-021xevidence.v1i2.2506","DOIUrl":"https://doi.org/10.17267/2675-021xevidence.v1i2.2506","url":null,"abstract":"OBJECTIVE: This study aimed to analyze the reporting and conduct characteristics of systematic reviews (SRs) published in dentistry by Brazilian corresponding authors and compare reporting characteristics of Brazilian SRs with the rest of the world. METHODS: A search in PubMed was performed to identify SRs published in dentistry in 2017 assessing different aspects of oral heath irrespective of the design of included studies. From this dataset, a subgroup analysis was performed considering only SRs published by Brazilian corresponding authors. Study screening was performed by two researchers independently, while for data extraction, one of three reviewers extracted details related to reporting and conduct of SRs. The completeness of reporting of 24 characteristics, included in the PRISMA Statement of the SRs classified as treatment/therapeutic, was evaluated comparing Brazilian SR to SRs from all other countries. RESULTS: We included 117 SRs with Brazilian corresponding authors. The majority focused on dental treatments (39.3%), with oral surgery (n=19, 16.2%) as the most commonly published. Included SRs presented varying reporting/conduct characteristics. Items such as use of reporting guidelines and screening method used were well reported. However, most SRs did not assess the risk of publication bias and did not use the GRADE assessment. Four (of 24) reporting characteristics of Brazilian SRs compared to SRs from the rest of world were reported statistically significantly more frequently: mention of a SR protocol, trial registry searched, screening method reported, and assessment of risk of bias/quality of studies. CONCLUSION: Reporting and conduct characteristics of Brazilian SRs are highly variable. ","PeriodicalId":55996,"journal":{"name":"International Journal of Evidence-Based Healthcare","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85076307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Evidence-Based Healthcare
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1